FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3499541018 | Interleukin-4 receptor alpha antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3649409017 | Substance with interleukin-4 receptor alpha antagonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3649410010 | Substance with interleukin-4 receptor alpha antagonist mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Interleukin-4 receptor alpha antagonist | Is a | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Interleukin-4 receptor alpha antagonist | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Interleukin receptor antagonist (disposition) | false | Inferred relationship | Some | ||
| Interleukin-4 receptor alpha antagonist | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Interleukin 4 receptor alpha antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dupilumab | Is a | True | Interleukin-4 receptor alpha antagonist | Inferred relationship | Some | |
| Interleukin-4 receptor alpha antagonist-containing product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Interleukin-4 receptor alpha antagonist | Inferred relationship | Some | 1 |
Reference Sets